NeuroPace Inc (NPCE) stock
NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3029% above fair value
$8.22+0.02 (+0.24%)
Close on Nov 18, 2026Market cap $282.15MP/E –Yield 0.00%
NeuroPace free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
NeuroPace's free cash flow for the twelve months ending Jun 30, 2026 was -$11.61M. For fiscal 2025 it was -$11.34M. The highest annual figure on record is -$11.34M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.34M | – |
| FY2024 | Dec 31, 2024 | -$18.26M | – |
| FY2023 | Dec 31, 2023 | -$19.87M | – |
| FY2022 | Dec 31, 2022 | -$37.47M | – |
| FY2021 | Dec 31, 2021 | -$24.96M | – |
| FY2020 | Dec 31, 2020 | -$21.67M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.03M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.02M | – |
| Q4 FY2025 | Dec 31, 2025 | $409.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.97M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.25M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.52M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.84M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.82M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.96M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.63M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.37M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.31M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.36M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.83M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.95M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.01M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.82M | – |
| Q1 FY2022 | Mar 31, 2022 | -$11.70M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.36M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.60M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.03M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.97M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.47M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.43M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.21M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.56M | – |
See a number that looks wrong?